The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Novel Adeno-Associated Virus Serotypes Efficiently Transduce Murine Photoreceptors
Open accessAbstract
Severe inherited retinal diseases, such as retinitis pigmentosa and Leber congenital amaurosis, are caused by mutations in genes preferentially expressed in photoreceptors. While adeno-associated virus (AAV)-mediated gene transfer can correct retinal pigment epithelium (RPE) defects in animal models, approaches for the correction of photoreceptor-specific diseases are less efficient. We evaluated the ability of novel AAV serotypes (AAV2/7, AAV2/8, AAV2/9, AAV2rh.43, AAV2rh.64R1, and AAV2hu.29R) in combination with constitutive or photoreceptor-specific promoters to improve photoreceptor transduction, a limiting step in photoreceptor rescue. Based on a qualitative analysis, all AAV serotypes tested efficiently transduce the RPE as well as rod and cone photoreceptors after subretinal administration in mice. Interestingly, AAV2/9 efficiently transduces Müller cells. To compare photoreceptor transduction from different AAVs and promoters in both a qualitative and quantitative manner, we designed a strategy based on the use of a bicistronic construct expressing both enhanced green fluorescent protein and luciferase. We found that AAV2/8 and AAV2/7 mediate six- to eightfold higher levels of in vivo photoreceptor transduction than AAV2/5, considered so far the most efficient AAV serotype for photoreceptor targeting. In addition, following subretinal administration of AAV, the rhodopsin promoter allows significantly higher levels of photoreceptor expression than the other ubiquitous or photoreceptor-specific promoters tested. Finally, we show that AAV2/7, AAV2/8, and AAV2/9 outperform AAV2/5 following ex vivo transduction of retinal progenitor cells differentiated into photoreceptors. We conclude that AAV2/7 or AAV2/8 and the rhodopsin promoter provide the highest levels of photoreceptor transduction both in and ex vivo and that this may overcome the limitation to therapeutic success observed so far in models of inherited severe photoreceptor diseases.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“RPE cells can be targeted using AAV1, AAV4, or AAV6 vectors or with the engineered AAV2-7m8 vector, and photoreceptors and Müller glial cells are targeted by serotypes AAV2, AAV5, AAV6, AAV7, AAV8, and AAV9 as well as engineered AAV2-7m8 and AAV8BP2 vectors.56,112–116”
From Gene Therapy for Retinal Degenerative Diseases: Progress, Challenges, and Future Directions (2023) · cites this paper as [114]
Citations
Cites
The Metabolic and Molecular Bases of Inherited Disease
Scriver, R. C. (1995) · Medical Entomology and Zoology · Cited by 12,101
Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy
Gao, G.-P., Alvira, M. R., Wang, L., Calcedo, R., Johnston, J., & Wilson, J. M. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.182412299 · Cited by 1,520
Self-citationGene therapy restores vision in a canine model of childhood blindness
Acland, G. M., Aguirre, G. D., Ray, J., Zhang, Q., Aleman, T. S., Cideciyan, A. V., Pearce-Kelling, S. E., Anand, V., Zeng, Y., Maguire, A. M., et al. (2001) · Nature Genetics · doi:10.1038/ng0501-92 · Cited by 1,202
Retinal Stem Cells in the Adult Mammalian Eye
Tropepe, V., Coles, B. L. K., Chiasson, B. J., Horsford, D. J., Elia, A. J., McInnes, R. R., & van der Kooy, D. (2000) · Science · doi:10.1126/science.287.5460.2032 · Cited by 1,081
Clades of Adeno-Associated Viruses Are Widely Disseminated in Human Tissues
Gao, G., Vandenberghe, L. H., Alvira, M. R., Lu, Y., Calcedo, R., Zhou, X., & Wilson, J. M. (2004) · Journal of Virology · doi:10.1128/jvi.78.12.6381-6388.2004 · Cited by 1,070
Self-citationRabinowitz, J. E., Rolling, F., Li, C., Conrath, H., Xiao, W., Xiao, X., & Samulski, R. J. (2002) · Journal of Virology · doi:10.1128/jvi.76.2.791-801.2002 · Cited by 762
New recombinant serotypes of AAV vectors
Gao, G., Vandenberghe, L., & Wilson, J. (2005) · Current Gene Therapy · doi:10.2174/1566523054065057 · Cited by 487
Self-citationHermonat, P. L., & Muzyczka, N. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.20.6466 · Cited by 481
Acland, G. M., Aguirre, G. D., Bennett, J., Aleman, T. S., Cideciyan, A. V., Bennicelli, J., Dejneka, N. S., Pearce-Kelling, S. E., Maguire, A. M., Palczewski, K., et al. (2005) · Molecular Therapy · doi:10.1016/j.ymthe.2005.08.008 · Cited by 477
Rutledge, E. A., Halbert, C. L., & Russell, D. W. (1998) · Journal of Virology · doi:10.1128/jvi.72.1.309-319.1998 · Cited by 452
Efficient photoreceptor-targeted gene expression in vivo by recombinant adeno-associated virus
Flannery, J. G., Zolotukhin, S., Vaquero, M. I., LaVail, M. M., Muzyczka, N., & Hauswirth, W. W. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.13.6916 · Cited by 407
Auricchio, A. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.26.3075 · Cited by 403
Self-citationCloning and Characterization of Adeno-Associated Virus Type 5
Chiorini, J. A., Kim, F., Yang, L., & Kotin, R. M. (1999) · Journal of Virology · doi:10.1128/jvi.73.2.1309-1319.1999 · Cited by 332
Ali, R. R., Sarra, G.-M., Stephens, C., Alwis, M. D., Bainbridge, J. W. B., Munro, P. M., Fauser, S., Reichel, M. B., Kinnon, C., Hunt, D. M., et al. (2000) · Nature Genetics · doi:10.1038/77068 · Cited by 304
Auricchio, A., Hildinger, M., O'Connor, E., Gao, G.-P., & Wilson, J. M. (2001) · Human Gene Therapy · doi:10.1089/104303401450988 · Cited by 297
Self-citationJacobson, S. G., Aleman, T. S., Cideciyan, A. V., Sumaroka, A., Schwartz, S. B., Windsor, E. A. M., Traboulsi, E. I., Heon, E., Pittler, S. J., Milam, A. H., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0500646102 · Cited by 274
Derouiche, A., & Rauen, T. (1995) · Journal of Neuroscience Research · doi:10.1002/jnr.490420115 · Cited by 263
Gene transfer into the mouse retina mediated by an adeno-associated viral vector
Ali, R. (1996) · Human Molecular Genetics · doi:10.1093/hmg/5.5.591 · Cited by 255
Functional and structural recovery of the retina after gene therapy in the RPE65 null mutation dog
Narfstro¨m, K., Katz, M. L., Bragadottir, R., Seeliger, M., Boulanger, A., Redmond, T. M., Caro, L., Lai, C.-M., & Rakoczy, P. E. (2003) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.02-0595 · Cited by 252
Cloning of adeno-associated virus type 4 (AAV4) and generation of recombinant AAV4 particles
Chiorini, J. A., Yang, L., Liu, Y., Safer, B., & Kotin, R. M. (1997) · Journal of Virology · doi:10.1128/jvi.71.9.6823-6833.1997 · Cited by 231
Sanges, D., Comitato, A., Tammaro, R., & Marigo, V. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0606276103 · Cited by 222
Self-citationHeparin binding directs activation of T cells against adeno-associated virus serotype 2 capsid
Vandenberghe, L. H., Wang, L., Somanathan, S., Zhi, Y., Figueredo, J., Calcedo, R., Sanmiguel, J., Desai, R. A., Chen, C. S., Johnston, J., et al. (2006) · Nature Medicine · doi:10.1038/nm1445 · Cited by 208 · cited 2×
“29R (55), and AAV2/5 (11) vectors harboring the AAV2 vector genome, coding for EGFP, under the control of the ubiquitous CMV promoter.”
BackgroundSelf-citationLe Meur, G., Stieger, K., Smith, A. J., Weber, M., Deschamps, J. Y., Nivard, D., Mendes-Madeira, A., Provost, N., Péréon, Y., Cherel, Y., et al. (2007) · Gene Therapy · doi:10.1038/sj.gt.3302861 · Cited by 207
Yang, G. S., Schmidt, M., Yan, Z., Lindbloom, J. D., Harding, T. C., Donahue, B. A., Engelhardt, J. F., Kotin, R., & Davidson, B. L. (2002) · Journal of Virology · doi:10.1128/jvi.76.15.7651-7660.2002 · Cited by 204
Weber, M., Rabinowitz, J., Provost, N., Conrath, H., Folliot, S., Briot, D., Chérel, Y., Chenuaud, P., Samulski, J., Moullier, P., et al. (2003) · Molecular Therapy · doi:10.1016/s1525-0016(03)00098-4 · Cited by 203
Tratschin, J. D., West, M. H., Sandbank, T., & Carter, B. J. (1984) · Molecular and Cellular Biology · doi:10.1128/mcb.4.10.2072 · Cited by 202
Efficacy of tribromoethanol anesthesia in mice.
Papaioannou, V. E., & Fox, J. G. (1993) · PubMed · Cited by 201
Molecular genetics of Leber congenital amaurosis
Cremers, F. P. M. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.10.1169 · Cited by 200
Pang, J.-J., Chang, B., Kumar, A., Nusinowitz, S., Noorwez, S. M., Li, J., Rani, A., Foster, T. C., Chiodo, V. A., Doyle, T., et al. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2005.09.001 · Cited by 199
In Utero Gene Therapy Rescues Vision in a Murine Model of Congenital Blindness
Dejneka, N. S., Surace, E. M., Aleman, T. S., Cideciyan, A. V., Lyubarsky, A., Savchenko, A., Redmond, T. M., Tang, W., Wei, Z., Rex, T. S., et al. (2004) · Molecular Therapy · doi:10.1016/j.ymthe.2003.11.013 · Cited by 197
Self-citationZeng, Y., Takada, Y., Kjellstrom, S., Hiriyanna, K., Tanikawa, A., Wawrousek, E., Smaoui, N., Caruso, R., Bush, R. A., & Sieving, P. A. (2004) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.04-0576 · Cited by 191
Min, S. H., Molday, L. L., Seeliger, M. W., Dinculescu, A., Timmers, A. M., Janssen, A., Tonagel, F., Tanimoto, N., Weber, B. H. F., Molday, R. S., et al. (2005) · Molecular Therapy · doi:10.1016/j.ymthe.2005.06.002 · Cited by 174
Jacobson, S. G., Boye, S. L., Alemán, T. S., Conlon, T. J., Zeiss, C. J., Román, A. J., Cideciyan, A. V., Schwartz, S., Komáromy, A. M., Doobrajh, M., et al. (2006) · Human Gene Therapy · doi:10.1089/hum.2006.17.845 · Cited by 157
National Cancer Institute (2020) · Definitions · doi:10.32388/j5tlqb · Cited by 153
AAV-Mediated gene transfer slows photoreceptor loss in the RCS rat model of retinitis pigmentosa
Smith, A. J., Schlichtenbrede, F. C., Tschernutter, M., Bainbridge, J. W., Thrasher, A. J., & Ali, R. R. (2003) · Molecular Therapy · doi:10.1016/s1525-0016(03)00144-8 · Cited by 147
Palczewski, K., Buczyłko, J., Lebioda, L., Crabb, J. W., & Polans, A. S. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53419-0 · Cited by 137
Jomary, C., Vincent, K. A., Grist, J., Neal, M., & Jones, S. (1997) · Gene Therapy · doi:10.1038/sj.gt.3300440 · Cited by 130
Sarra, G. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.21.2353 · Cited by 127
Pawlyk, B. S., Smith, A. J., Buch, P. K., Adamian, M., Hong, D.-H., Sandberg, M. A., Ali, R. R., & Li, T. (2005) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.05-0371 · Cited by 126
Delhaye, S., Pesch, V. V., & Michiels, T. (2004) · Journal of Virology · doi:10.1128/jvi.78.8.4357-4362.2004 · Cited by 120
Adeno-Associated Virus-Vectored Gene Therapy for Retinal Disease
Dinculescu, A., Glushakova, L. G., Min, S.-H., & Hauswirth, W. W. (2005) · Human Gene Therapy · doi:10.1089/hum.2005.16.649 · Cited by 109
Lotery, A. J., Yang, G. S., Mullins, R. F., Russell, S. R., Schmidt, M., Stone, E. M., Lindbloom, J. D., Chiorini, J. A., Kotin, R. M., & Davidson, B. L. (2003) · Human Gene Therapy · doi:10.1089/104303403322542301 · Cited by 107 · cited 2×
“Among the various AAV vectors tested so far in the retina, AAV2/1 and AAV2/4 are considered ideal vectors for RPE gene transfer (7, 51, 56, 57), and AAV2/5 is considered ideal for photoreceptor transduction (7, 37).”
BackgroundResultPharmacological Regulation of Protein Expression from Adeno-Associated Viral Vectors in the Eye
Auricchio, A., Rivera, V. M., Clackson, T., O'Connor, E. E., Maguire, A. M., Tolentino, M. J., Bennett, J., & Wilson, J. M. (2002) · Molecular Therapy · doi:10.1006/mthe.2002.0660 · Cited by 89
Self-citationSchlichtenbrede, F. C., da Cruz, L., Stephens, C., Smith, A. J., Georgiadis, A., Thrasher, A. J., Bainbridge, J. W., Seeliger, M. W., & Ali, R. R. (2003) · The Journal of Gene Medicine · doi:10.1002/jgm.401 · Cited by 87
Evaluation of recombinant adeno-associated virus as a gene transfer vector for the retina
Grant, C. A., Ponnazhagan, S., Wang, X.-S., Srivastava, A., & Li, T. (1997) · Current Eye Research · doi:10.1076/ceyr.16.9.949.5046 · Cited by 86
A Composite CMV-IE Enhancer/β-Actin Promoter Is Ubiquitously Expressed in Mouse Cutaneous Epithelium
Sawicki, J. A., Morris, R. J., Monks, B. R., Sakai, K., & Miyazaki, J. (1998) · Experimental Cell Research · doi:10.1006/excr.1998.4175 · Cited by 76
Intraocular Delivery of Recombinant Virus
Liang, F.-Q., Anand, V., Maguire, A. M., & Bennett, J. (2003) · Humana Press eBooks · doi:10.1385/1-59259-085-3:125 · Cited by 72
Gene therapy and retinitis pigmentosa: advances and future challenges
Dejneka, N. S., & Bennett, J. (2001) · BioEssays · doi:10.1002/bies.1092 · Cited by 53
AAV-mediated gene transfer for retinal diseases
Allocca, M., Tessitore, A., Cotugno, G., & Auricchio, A. (2006) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.6.12.1279 · Cited by 50
Self-citationHennig, A. K., Ogilvie, J. M., Ohlemiller, K. K., Timmers, A. M., Hauswirth, W. W., & Sands, M. S. (2004) · Molecular Therapy · doi:10.1016/j.ymthe.2004.03.018 · Cited by 49
Young, J. E., Vogt, T. M., Gross, K. W., & Khani, S. C. (2003) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.03-0197 · Cited by 48
High throughput production, screening and analysis of adeno-associated viral vectors
Drittanti, L., Rivet, C., Manceau, P., Danos, O., & Vega, M. T. (2000) · Gene Therapy · doi:10.1038/sj.gt.3301191 · Cited by 48
Surace, E. M., Auricchio, A., Reich, S. J., Rex, T., Glover, E., Pineles, S., Tang, W., O'Connor, E., Lyubarsky, A., Savchenko, A., et al. (2003) · Journal of Virology · doi:10.1128/jvi.77.14.7957-7963.2003 · Cited by 46
Self-citationHo, T. T., Maguire, A. M., Aguirre, G. K., Surace, E. M., Anand, V., Zeng, Y., Salvetti, A., Hopwood, J. J., Haskins, M. E., & Bennett, J. (2002) · The Journal of Gene Medicine · doi:10.1002/jgm.302 · Cited by 43
Self-citationAdeno-Associated Viral Vectors for Retinal Gene Transfer and Treatment of Retinal Diseases
Auricchio, A., & Rolling, F. (2005) · Current Gene Therapy · doi:10.2174/1566523054065020 · Cited by 43
Self-citationSurace, E. M., Domenici, L., Cortese, K., Cotugno, G., Vicino, U. D., Venturi, C. B., Cellerino, A., Marigo, V., Tacchetti, C., Ballabio, A., et al. (2005) · Molecular Therapy · doi:10.1016/j.ymthe.2005.06.001 · Cited by 42
Self-citationRecent advances in the molecular basis of inherited photoreceptor degeneration
Clarke, G. D., Héon, E., & McInnes, R. R. (2000) · Clinical Genetics · doi:10.1034/j.1399-0004.2000.570501.x · Cited by 37
Commentary: An Aye for Eye Gene Therapy
Bennett, J. (2006) · Human Gene Therapy · doi:10.1089/hum.2006.17.177 · Cited by 22
Glushakova, L. G., Timmers, A. M., Issa, T., Cortez, N. G., Pang, J., Teusner, J. T., & Hauswirth, W. W. (2006) · PubMed · Cited by 19
Research works printed but not linked: 3
- Dryja, T. 2001. Retinitis pigmentosa and stationary night blindness, p.5903 -5933. In C. R. Scriver, A. L. Beaudet, W. Sly, and D. M. Valle (ed.), The metabolic and molecular bases of inherited disease, 8th ed.,vol. IV. McGraw-Hill, New York, NY.
- Gregory-Evans, K., and R. G. Weleber. 2001. Retinitis pigmentosa and allied disorders in retina, p.362-460. In S. J. Ryan (ed.), Retinavol. 1, 3rd ed. Mosby, St. Louis, MO.
- 10.1128/mcb.4.10.2072-2081.1984 · doi:10.1128/mcb.4.10.2072-2081.1984 · Paper page
Cited by
Genetic Reactivation of Cone Photoreceptors Restores Visual Responses in Retinitis Pigmentosa
Busskamp, V., Duebel, J., Balya, D., Fradot, M., Viney, T. J., Siegert, S., Groner, A. C., Cabuy, E., Forster, V., Seeliger, M., et al. (2010) · Science · doi:10.1126/science.1190897 · Cited by 642
Ultra light-sensitive and fast neuronal activation with the Ca2+-permeable channelrhodopsin CatCh
Kleinlogel, S., Feldbauer, K., Dempski, R. E., Fotis, H., Wood, P. G., Bamann, C., & Bamberg, E. (2011) · Nature Neuroscience · doi:10.1038/nn.2776 · Cited by 476
Krol, J., Busskamp, V., Markiewicz, I., Stadler, M. B., Ribi, S., Richter, J., Duebel, J., Bicker, S., Fehling, H. J., Schübeler, D., et al. (2010) · Cell · doi:10.1016/j.cell.2010.03.039 · Cited by 470
Dias, M. F., Joo, K., Kemp, J. A., Fialho, S. L., da Silva Cunha, A., Woo, S. J., & Kwon, Y. J. (2018) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2017.10.004 · Cited by 413
High-efficiency transduction of the mouse retina by tyrosine-mutant AAV serotype vectors
Petrs-Silva, H., Dinculescu, A., Li, Q., Min, S.-H., Chiodo, V., Pang, J.-J., Zhong, L., Zolotukhin, S., Srivastava, A., Lewin, A. S., et al. (2009) · Molecular Therapy · doi:10.1038/mt.2008.269 · Cited by 398
Metadata
- Authors
- Allocca, M., Mussolino, C., Garcia-Hoyos, M., Sanges, D., Iodice, C., Petrillo, M., Vandenberghe, L. H., Wilson, J. M., Marigo, V., Surace, E. M., & Auricchio, A.
- Affiliations
- European School of Molecular Medicine (IT)
- Telethon Institute of Genetics and Medicine (TIGEM), Naples, Italy
- University of Modena and Reggio Emilia (IT)
- Telethon Institute Of Genetics And Medicine (IT)
- University of Pennsylvania (US)
- Federico II University Hospital (IT)
- ORCID
- Venue
- Journal of Virology
- Publisher
- American Society for Microbiology
- Published
- 2007-10-15
- Volume
- 81
- Issue
- 20
- Pages
- 11372-11380
- ISSN
- 0022-538X (ISSN-L)
- 1098-5514
- PMC
- PMC2045569
- OpenAlex
- W2155190242
- Cited by
- 246
- References
- 59
- Citations by year
- 2026: 11 · 2025: 9 · 2024: 6 · 2023: 10 · 2022: 11 · 2021: 14 · 2020: 10 · 2019: 14 · 2018: 12 · 2017: 16 · 2016: 7 · 2015: 30 · 2014: 11 · 2013: 16 · 2012: 13
- FWCI
- 5.73
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Journal of Virology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- IRIS UNIMORE (University of Modena and Reggio Emilia) (submittedVersion, cc-by)
- Funders
- National Eye Institute (R01EY015136)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Health Sciences › Medicine › Ophthalmology › Retinal Development and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Keywords
- adeno-associated virus serotypes, phototransduction, AAV2/8, AAV2/9, rhodopsin promoter, retinitis pigmentosa, Leber congenital amaurosis, inherited retinal disease, subretinal gene therapy, Müller cells, retinal progenitor cells, AAV2/5, luciferase reporter
- MeSH terms
- Dependovirus, Animals, Genetic Vectors, Photoreceptor Cells, Promoter Regions, Genetic, Retina, Rhodopsin, Serotyping, Transduction, Genetic, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.